Efficacy of Isa-VRd as first-line therapy in newly diagnosed MM
We summarize results from a phase III trial evaluating the safety and efficacy of Isa-VRd vs VRd in adult patients with newly diagnosed MM who were eligible for transplantation.
Related Articles
How a stem cell transplant changed the life — and blood — of a leukemia patient
A stem cell donor changed Laura Tiberi’s life after her leukemia diagnosis. Now she’s sharing hope and inspiration with other transplant recipients.
New Tool Can Help Improve Health Equity in Cancer Centers : Oncology Times
An abstract is unavailable.
Dostarlimab Plus Chemo Earns Positive CHMP Opinion for Expanded Indication in Advanced Endometrial Cancer
The EMA’s CHMP has recommended the approval of an expanded indication for dostarlimab plus chemotherapy in primary advanced/recurrent endometrial cancer.
Mosunetuzumab Plus Polatuzumab Vedotin Shows Improved Outcomes vs Rituximab Plus Polatuzumab Vedotin Among Patients With R/R Large B-Cell Lymphoma
Subcutaenous mosunetuzumab plus polatuzumab vedotin demonstrates improved efficacy and response rates compared with rituximab plus polatuzumab vedotin for patients with relapsed/refractory (R/R) LBCL, according to…
Fox Chase Honors Those Touched by Cancer with 2024 Tree of Life Celebration
Every holiday season, Fox Chase Cancer Center’s Tree of Life Celebration brings together patients, families, donors, researchers, and medical staff to pay tribute to all…
FDA Grants Priority Review to Sunvozertinib in EGFR+ NSCLC
The FDA granted priority review to sunvozertinib for the treatment of advanced NSCLC with EGFR exon 20 mutations, based on promising efficacy and safety data…
Crunching the numbers for next-gen COVID-19 vaccines
BARDA tapped a team of Fred Hutch Cancer Center biostatisticians to determine the biomarkers that will serve as predictors of protective responses in next-generation COVID-19…
Bristol Old Vic theatre school to stop its undergraduate courses
Renowned drama school says ‘unprecedented funding challenges’ make degrees unviable from September 2025
Comorbid conditions and survival among Black women with ovarian cancer
In a population-based study of Black women with ovarian cancer, a higher Charlson comorbidity index based on self-reported data and type 2 diabetes were associated…
Clive Peedell (@drpeedell.bsky.social)
Consultant Clinical Oncologist NHS advocate and campaigner Politically centre left Wealth inequality creates health inequality